Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06827977 · ClinicalTrials.gov registry record · Phase 2
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
A Phase 2 study of Constipation and Bloating, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT06827977 is a Phase 2 study of Constipation and Bloating that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 21 participants, below the 205-participant average among 54 other Constipation trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06827977, a Phase 2 study of Constipation and Bloating, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the intestinal flora in subjects with systemic sclerosis-related constipation and/or significant bloating and to determine safety and trends in improvements in the diversity of colonic microbiome and patient symptoms following the administration of either frozen or lyophilized PRIM-DJ2727 microbiota.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG PRIM-DJ2727
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2026-09-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06827977
The ClinicalTrials.gov registry entry for NCT06827977 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 54 other Constipation trials with a reported enrollment target (90% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Constipation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06827977 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06827977 about?
NCT06827977 is a clinical study titled "A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis". The purpose of this study is to characterize the intestinal flora in subjects with systemic sclerosis-related constipation and/or significant bloating and to determine safety and trends in improvements in the diversity of colonic microbiome and patient symptoms following the administration of either...
What is the current status of trial NCT06827977?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2025-03-03. Estimated completion is 2026-09-26.
What conditions does trial NCT06827977 study?
This clinical trial studies the following conditions: Constipation, Bloating.
What interventions are being tested in trial NCT06827977?
The interventions under investigation include: Placebo (DRUG), PRIM-DJ2727 (DRUG).
Who is sponsoring clinical trial NCT06827977?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06827977 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
RECRUITING · Phase 2
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Use of a Squatting Assist Device in Patients With Constipation
ACTIVE NOT RECRUITING · Phase 2
-
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
COMPLETED · Phase 2
-
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.